The Venture Codex

Led · Series D · Jul 2026

AdvanCell develops targeted alpha radiopharmaceutical therapies built around a proprietary Lead-212 platform that combines secure isotope supply, automated manufacturing and scalable production. Its lead program, ADVC001, is a Lead-212 PSMA-targeted alpha therapy for metastatic prostate cancer that has shown encouraging Phase 1b anti-tumor activity and favorable tolerability and is currently in Phase 2 clinical development. The company emphasizes vertical integration — spanning isotope supply, advanced manufacturing and clinical development — to address supply and manufacturing constraints for targeted alpha therapies. With integrated operations across North America and Australia, AdvanCell plans to expand U.S. manufacturing infrastructure to support Phase 3 development and future commercial demand. The recent US $315 million Series D financing is intended to advance ADVC001 toward registrational development and accelerate the company’s growing pipeline of targeted alpha therapies.

Participated · Series F · Jun 2026

Ramp started as an expense-management platform and has expanded into payments, fraud detection, procurement, vendor management and accounting while integrating AI capabilities across its product suite. The company says it has more than 70,000 customers, including Visa, Uber, Shopify, Anduril and Figma, up from 50,000 last November. Ramp reported annualized revenue of more than $1 billion (with Bloomberg reporting a run-rate above $1.5 billion) and said it has reached positive free cash flow. It has launched AI-focused features such as AI agents for procurement, expense management, accounting and budgeting, and even a corporate credit card intended for AI-agent use. Ramp has raised over $3 billion in total capital to date. Management has indicated an eventual aim to go public, though no timing was given.

Participated · Series D · May 2026

Cognition develops Devin, an autonomous AI software engineer designed to write and maintain code. The company acquired the remaining parts of Windsurf last year and positions itself against other model makers in the coding space. Cognition counts enterprise customers including Mercedes-Benz, NASA, Goldman Sachs and Santander. It reported a $492 million annualized revenue run-rate and said enterprise usage of Devin grew roughly 50% month-over-month for six months. The company has demonstrated rapid commercial adoption, which it cited alongside its latest financing.

Participated · Equity · Mar 2026

Nxtra operates one of India’s largest data center networks with around 300 MW of capacity across 14 core data centers and over 120 edge sites. The company offers colocation, cloud infrastructure, disaster recovery and edge computing services and is positioning itself as an AI-driven infrastructure provider using AI for predictive maintenance, energy efficiency and automated operations. Nxtra plans to scale capacity to 1 GW over the next few years and is targeting roughly 25% market share in India’s expanding data center market. It is expanding its pipeline with new AI-ready campuses in cities such as Chennai, Mumbai and Kolkata and pursuing partnerships with global technology companies for large-scale deployments. The company was valued at approximately $3.1 billion post-closing after the announced $1 billion investment led by Alpha Wave Global, Carlyle and Anchorage Capital, with Airtel retaining control.

Participated · Series G · Feb 2026

Anthropic is a premier artificial intelligence safety and research company renowned for developing Claude, a family of highly capable, steerable, and safe large language models. Founded by former OpenAI researchers, Anthropic pioneers techniques like "Constitutional AI" to build systems that are helpful, honest, and harmless. Beyond its core research, the company has rapidly scaled into a dominant market force, experiencing exponential revenue growth driven by widespread enterprise adoption. Anthropic has attracted unprecedented investor attention, recently raising approximately $30 billion at a $380 billion valuation, with ongoing negotiations potentially boosting its valuation to roughly $800 billion. As a leading competitor in the generative AI space, the company is reportedly exploring an IPO later this year.